Saturday, February 4, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Areas
Cover Stories
Great Expectations
With the soaring costs of bringing a drug to market blowing holes in Big Pharma’s profits, NGP looks at how AstraZeneca’s David Brennan,...
Securing the Message
With e-mail remaining the most pervasive means of communication in the financial services industry, organizations are under increased scrutiny...
Time to Change?
The business and technology model for ATM networks has remained virtually unchanged since these devices were first installed. So is a new...
Roundtables
-
Driving Discovery
Drug discovery needs all the help it can get. NGP talks problems and solutions with four gene genies: IQuum’s Shuqi Chen, Sequenom’s Elizabeth Dragon, Cellumen’s D. Lansing...Read more -
DNA Sequencing
To find out more about the world of DNA sequencing, NGP asked Christopher K McLeod, President and Chief Executive Officer, 454 Life Sciences Corporation and Robert...Read more -
Marketing Success
NGP spoke with Neil W Matheson, CEO of AXIS Healthcare Communications LLC; Peter Gannon, Hyphen’s Senior Vice President responsible for Client Services and Business...Read more
Industry Analysts
-
How to… Manage Pharma’s Mid-Life Crisis
Kathy Magnuson, EVP and Managing Director for Brand Pharm, looks at managing the mid-lifecycle crisis in pharmaceutical promotion.Read more -
How Do You Recruit the Best Workforce?
There is a war for talent in the pharmaceutical/biotech industry like never before. So how can you find the top workforce candidates for your company when everyone is...Read more
Executive Interviews
A New Era for MicroRNA
Berta Strulovici, Vice-President Research, Automated Biotechnology Dept, Merck & Co. speaks with NGP, and provides some insight into the recent emergence of MicroRNA.
Read more
Biomark My Words
Biomarkers are playing an increasingly important role in the development of new drugs to fight disease. In this revealing interview, Dr. Werner Kroll, Global Head of Biomarker Development at Novartis, gives us his view on the development of this e...
Read more
The Appliance of IT in Science
NGP catches up with Geoff Odell, Chairman of the LSIT Global Institute and CIO of the Novartis Genomic Research Institute, to discover how instrumental IT is to the life science drug pipeline.
Read more
Next Generation Healthcare Summit
25th - 27th October 2010
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.